Evidence map›Paper›PMID 20830443›Full record

ArticleChemical communications (Cambridge, England)2010

Highly efficient chemoenzymatic synthesis of β1-3-linked galactosides.

Hai Yu, Vireak Thon, Kam Lau, Li Cai, Yi Chen, Shengmao Mu, Yanhong Li, Peng George Wang, Xi Chen

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Review
  3. A bifunctionalOrganic & biomolecular chemistry · 2024
    Article
  4. Article
  5. Article
  6. Food chemistry: X · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Lacto-iScience · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hai YuDepartment of Chemistry, University of California, One Shields Avenue, Davis, California 95616, USA.
Vireak Thon
Kam Lau
Li Cai
Yi Chen
Shengmao Mu
Yanhong Li
Peng George Wang
Xi Chen
University of California, Davis · USThe Ohio State University · US

Funding

Neu5Gc and anti-Neu5Gc antibodies for detection of cancer and cancer riskU01CA128442 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VARKI, AJIT P · 2007 to 2011
$2.1M
Studies of Naturally Occurring Structurally Modified CarbohydratesR01GM076360 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, XI · 2006 to 2010
$1.9M
Investigation on Oligosaccharides as Antimicrobial and PrebioticsR01HD061935 · NICHD · OHIO STATE UNIVERSITY · PI WANG, PENG GEORGE · 2009 to 2013
$1.6M
NCI NIH HHS U01 CA128442NCI NIH HHS U01CA128442NICHD NIH HHS R01 HD061935NICHD NIH HHS R01HD061935NIGMS NIH HHS R01 GM076360NIGMS NIH HHS R01GM076360
6 · The paper itself

Abstract

A novel D-galactosyl-β1-3-N-acetyl-D-hexosamine phosphorylase cloned from Bifidobacterium infantis (BiGalHexNAcP) was used with a recombinant E. coli K-12 galactokinase (GalK) for efficient one-pot two-enzyme synthesis of T-antigens, galacto-N-biose (Galβ1-3GalNAc), lacto-N-biose (Galβ1-3GlcNAc), and their derivatives.

Indexed as

BifidobacteriumEscherichia coliGalactosidesGalactosyltransferasesIndustrial MicrobiologyMolecular Structurebeta-1,3-galactosyl-N-acetylhexosamine phosphorylaseGalactosidesGalactosyltransferases

Identifiers

PMID20830443
PMCPMC3114946
OpenAlexW1977503027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.